TRANSBIO study in Renal Transplantation is an ongoing, international study (conducted in 10 Europe and USA hospitals) that will allow to confirm the results of the PoC study in Renal Transplantation, and that will also allow to test IMBG reproducibility. Final results are expected in September 2019.

Regarding Rheumatoid Arthritis, once the feasibility and robustness of IMBG in this disease have been demonstrated with the BH-Pilot Study 2018, a subsequent validation study is planned to be carried out at international level.